Daniel J. Dairaghi

3.4k total citations
33 papers, 2.7k citations indexed

About

Daniel J. Dairaghi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Daniel J. Dairaghi has authored 33 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Daniel J. Dairaghi's work include Chemokine receptors and signaling (19 papers), T-cell and B-cell Immunology (9 papers) and Cytomegalovirus and herpesvirus research (6 papers). Daniel J. Dairaghi is often cited by papers focused on Chemokine receptors and signaling (19 papers), T-cell and B-cell Immunology (9 papers) and Cytomegalovirus and herpesvirus research (6 papers). Daniel J. Dairaghi collaborates with scholars based in United States, France and United Kingdom. Daniel J. Dairaghi's co-authors include Thomas J. Schall, David A. Clayton, Gerald S. Shadel, Mark E.T. Penfold, Noah Saederup, Edward S. Mocarski, Michael R. Hanley, Juan C. Jaén, Kevin B. Bacon and George Kemble and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Daniel J. Dairaghi

33 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel J. Dairaghi United States	25	1.4k	951	622	618	270	33	2.7k
Monika Pruenster Germany	27	1.4k 1.0×	683 0.7×	628 1.0×	232 0.4×	196 0.7×	35	2.4k
Michel Ticchioni France	30	1.3k 0.9×	343 0.4×	791 1.3×	229 0.4×	124 0.5×	72	2.7k
Sami Alouani France	19	1.5k 1.1×	860 0.9×	894 1.4×	384 0.6×	79 0.3×	32	2.6k
Jaime Llodrá United States	11	2.1k 1.5×	706 0.7×	745 1.2×	513 0.8×	127 0.5×	14	3.0k
Niels Bovenschen Netherlands	29	1.1k 0.8×	531 0.6×	945 1.5×	283 0.5×	114 0.4×	83	2.7k
Pierre Eid France	24	1.4k 1.0×	712 0.7×	548 0.9×	434 0.7×	82 0.3×	47	2.4k
Mark Birkenbach United States	29	1.8k 1.3×	2.0k 2.1×	581 0.9×	783 1.3×	142 0.5×	54	3.9k
Hiromi Kubagawa United States	40	4.2k 3.0×	418 0.4×	1.4k 2.2×	253 0.4×	217 0.8×	102	5.8k
Stéphanie Graff‐Dubois France	23	1.4k 1.0×	364 0.4×	577 0.9×	314 0.5×	102 0.4×	39	2.0k
Andrés Jaramillo United States	28	1.3k 0.9×	373 0.4×	325 0.5×	411 0.7×	325 1.2×	96	2.9k

Countries citing papers authored by Daniel J. Dairaghi

Since Specialization

Citations

This map shows the geographic impact of Daniel J. Dairaghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Dairaghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Dairaghi more than expected).

Fields of papers citing papers by Daniel J. Dairaghi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Dairaghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Dairaghi. The network helps show where Daniel J. Dairaghi may publish in the future.

Co-authorship network of co-authors of Daniel J. Dairaghi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Dairaghi. A scholar is included among the top collaborators of Daniel J. Dairaghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Dairaghi. Daniel J. Dairaghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bekker, Pirow, Daniel J. Dairaghi, Lisa Seitz, et al.. (2016). Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study. PLoS ONE. 11(10). e0164646–e0164646. 115 indexed citations

Duliège, Anne‐Marie, Stefan Sleijfer, A. Bischof, et al.. (2015). Abstract CT223: CCX872: Pharmacodynamic study of a potent and selective CCR2 antagonist in human volunteers and plans for phase Ib trial in patients with pancreatic cancer. Cancer Research. 75(15_Supplement). CT223–CT223. 2 indexed citations

Sullivan, Timothy J., Zhenhua Miao, Daniel J. Dairaghi, et al.. (2013). CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice. American Journal of Physiology-Renal Physiology. 305(9). F1288–F1297. 76 indexed citations

Jaén, Juan C., et al.. (2013). FRI0002 Inhibition of chemokine receptors ccr1 and ccr6 as promising therapies for rheumatoid arthritis. Annals of the Rheumatic Diseases. 72. A369–A369. 2 indexed citations

Pennell, Andrew M. K., James B. Aggen, Subhabrata Sen, et al.. (2013). 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 23(5). 1228–1231. 11 indexed citations

Xiao, Hong, Daniel J. Dairaghi, Jay P. Powers, et al.. (2013). C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN. Journal of the American Society of Nephrology. 25(2). 225–231. 257 indexed citations

Walters, Matthew J., Yu Wang, Trageen Baumgart, et al.. (2010). Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease. Journal of Pharmacology and Experimental Therapeutics. 335(1). 61–69. 130 indexed citations

Rosenblum, Joshua, Qi‐Wei Zhang, Gerald Siu, et al.. (2009). CXCR3 Antagonism Impairs the Development of Donor-Reactive, IFN-γ-Producing Effectors and Prolongs Allograft Survival. Transplantation. 87(3). 360–369. 33 indexed citations

Burns, Jennifer M., et al.. (2002). Comprehensive Mapping of Poxvirus vCCI Chemokine-binding Protein. Journal of Biological Chemistry. 277(4). 2785–2789. 57 indexed citations

10.

Tong, Ning, Seth W. Perry, Qing Zhang, et al.. (2000). Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System. The Journal of Immunology. 164(3). 1333–1339. 154 indexed citations

11.

Gosling, Jennifa, Daniel J. Dairaghi, Yu Wang, et al.. (2000). Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK. The Journal of Immunology. 164(6). 2851–2856. 159 indexed citations

12.

Franz-Bacon, Karin, Daniel J. Dairaghi, Stefen A. Boehme, et al.. (1999). Human Thymocytes Express CCR-3 and Are Activated by Eotaxin. Blood. 93(10). 3233–3240. 24 indexed citations

13.

Dairaghi, Daniel J., et al.. (1999). HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8. Journal of Biological Chemistry. 274(31). 21569–21574. 149 indexed citations

14.

Schwaeble, Wilhelm, Cordula Stover, Thomas J. Schall, et al.. (1998). Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Letters. 439(3). 203–207. 88 indexed citations

15.

Dairaghi, Daniel J., Kenneth Soo, Elizabeth R. Oldham, et al.. (1998). RANTES-Induced T Cell Activation Correlates with CD3 Expression. The Journal of Immunology. 160(1). 426–433. 46 indexed citations

16.

Bacon, Kevin B., Thomas J. Schall, & Daniel J. Dairaghi. (1998). RANTES Activation of Phospholipase D in Jurkat T Cells: Requirement of GTP-Binding Proteins ARF and RhoA. The Journal of Immunology. 160(4). 1894–1900. 44 indexed citations

17.

Dairaghi, Daniel J., Elizabeth R. Oldham, Kevin B. Bacon, & Thomas J. Schall. (1997). Chemokine Receptor CCR3 Function Is Highly Dependent on Local pH and Ionic Strength. Journal of Biological Chemistry. 272(45). 28206–28209. 48 indexed citations

18.

Greaves, David R., Wei Wang, Daniel J. Dairaghi, et al.. (1997). CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells. The Journal of Experimental Medicine. 186(6). 837–844. 307 indexed citations

19.

Dairaghi, Daniel J., Gerald S. Shadel, & David A. Clayton. (1995). Human mitochondrial transcription factor A and promoter spacing integrity are required for transcription initiation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1271(1). 127–134. 71 indexed citations

20.

Schmitt, Mark E., Jeffrey Bennett, Daniel J. Dairaghi, & David A. Clayton. (1993). Secondary structure of RNase MRP RNA as predicted by phylogenetic comparison.. The FASEB Journal. 7(1). 208–213. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact